MSFT 437.49 1.4587% AAPL 242.99 0.1401% NVDA 145.11 3.4579% GOOGL 174.36 1.7626% GOOG 176.05 1.7512% AMZN 218.21 2.2348% META 613.54 -0.0179% AVGO 170.365 1.3173% TSLA 357.75 1.8013% TSM 200.69 0.905% LLY 833.585 2.4904% V 310.57 -0.7795% JPM 243.555 -0.5167% UNH 610.73 0.9087% NVO 109.26 0.0549% WMT 94.295 0.8395% LVMUY 127.2 -0.9269% XOM 114.29 -2.8724% LVMHF 638.8 -0.6084% MA 521.685 -0.8543%
Last update at 2024-12-04T20:52:00Z
Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report?
Thu 17 Oct 24, 04:10 PMElanco Confirms Date and Conference Call for Third Quarter 2024 Financial Results Announcement
Thu 10 Oct 24, 12:00 PMElanco Provides Update on Contract Manufacturing Partner
Fri 13 Sep 24, 11:30 AMBullish Elanco Animal Health Insiders Loaded Up On US$2.23m Of Stock
Fri 06 Sep 24, 04:05 PMElanco to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference
Wed 28 Aug 24, 10:30 AMElanco Announces Credelio Quattro Moves to Final FDA Administrative Review
Tue 20 Aug 24, 10:27 AM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | -66.00000M | -567.00000M | -672.00000M | 78.20M | 114.10M |
| Minority interest | - | - | - | - | - |
| Net income | -74.00000M | -472.00000M | -560.10000M | 67.90M | 86.50M |
| Selling general administrative | 1266.00M | 1404.00M | 996.60M | 760.20M | 735.20M |
| Selling and marketing expenses | - | - | 996.00M | - | - |
| Gross profit | 2505.00M | 2631.00M | 1606.70M | 1600.70M | 1493.00M |
| Reconciled depreciation | 528.00M | 556.00M | 516.90M | 314.50M | 296.00M |
| Ebit | 358.00M | 297.00M | 101.50M | 342.60M | 442.60M |
| Ebitda | 886.00M | 853.00M | 461.40M | 543.00M | 640.00M |
| Depreciation and amortization | 528.00M | 556.00M | 359.90M | 200.40M | 197.40M |
| Non operating income net other | -32.00000M | -5.00000M | 178.30M | -27.40000M | -41.30000M |
| Operating income | 358.00M | 297.00M | 101.50M | 342.60M | 313.80M |
| Other operating expenses | 4028.00M | 4463.00M | 3350.10M | 2701.00M | 2753.00M |
| Interest expense | 241.00M | 236.00M | 149.80M | 78.90M | 29.60M |
| Tax provision | 8.00M | -95.00000M | -111.90000M | 10.30M | 27.60M |
| Interest income | - | - | - | 78.90M | 29.60M |
| Net interest income | -241.00000M | -236.00000M | -149.80000M | -78.90000M | -29.60000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | 183.00M | 628.00M | 623.70M | 185.50M | 128.80M |
| Other items | - | - | - | - | - |
| Income tax expense | 8.00M | -95.00000M | -111.90000M | 10.30M | 27.60M |
| Total revenue | 4418.00M | 4765.00M | 3273.30M | 3071.00M | 3066.80M |
| Total operating expenses | 2115.00M | 2329.00M | 1683.50M | 1230.70M | 1179.20M |
| Cost of revenue | 1913.00M | 2134.00M | 1666.60M | 1470.30M | 1573.80M |
| Total other income expense net | -424.00000M | -864.00000M | -773.50000M | -264.40000M | -170.10000M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -74.00000M | -472.00000M | -560.10000M | 67.90M | 86.50M |
| Net income applicable to common shares | -78.00000M | -472.00000M | -560.10000M | 67.90M | 86.50M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 15491.00M | 16483.00M | 17692.70M | 8985.80M | 8956.70M |
| Intangible assets | 4842.00M | 5587.00M | 6387.30M | 2482.80M | 2453.00M |
| Earning assets | - | - | - | - | - |
| Other current assets | 394.00M | 237.00M | 256.30M | 87.40M | 113.90M |
| Total liab | 8202.00M | 8945.00M | 9216.80M | 3438.90M | 3759.20M |
| Total stockholder equity | 7289.00M | 7538.00M | 8475.90M | 5546.90M | 5197.50M |
US 
AU
UK
CA
NZ